FBR & Co reiterated their outperform rating on shares of Ducommun Inc. (NYSE:DCO) in a research note issued to investors on Friday morning. FBR & Co currently has a $30.00 target price on the stock, up from their prior target price of $28.00.

A number of other research firms have also recently commented on DCO. Zacks Investment Research cut Ducommun from a strong-buy rating to a hold rating in a report on Tuesday, October 18th. Canaccord Genuity reaffirmed a buy rating and issued a $25.00 target price on shares of Ducommun in a report on Sunday, August 7th. Finally, B. Riley reaffirmed a buy rating and issued a $26.75 target price on shares of Ducommun in a report on Sunday, November 6th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $23.96.

Ducommun (NYSE:DCO) traded down 0.80% during trading on Friday, reaching $26.03. The company’s stock had a trading volume of 8,583 shares. The company’s market cap is $290.83 million. The stock has a 50-day moving average price of $21.91 and a 200 day moving average price of $20.49. Ducommun has a 52-week low of $12.28 and a 52-week high of $27.15.

In other Ducommun news, VP Rose F. Rogers sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $24.29, for a total transaction of $121,450.00. Following the completion of the transaction, the vice president now owns 32,816 shares in the company, valued at $797,100.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP James S. Heiser sold 2,012 shares of the business’s stock in a transaction that occurred on Wednesday, November 9th. The shares were sold at an average price of $22.90, for a total value of $46,074.80. Following the transaction, the vice president now owns 15,850 shares of the company’s stock, valued at approximately $362,965. The disclosure for this sale can be found here. Company insiders own 9.10% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in DCO. JPMorgan Chase & Co. acquired a new position in shares of Ducommun during the third quarter valued at about $103,000. First Manhattan Co. acquired a new position in shares of Ducommun during the second quarter valued at about $113,000. The Manufacturers Life Insurance Company acquired a new position in shares of Ducommun during the third quarter valued at about $176,000. Metropolitan Life Insurance Co. NY acquired a new position in shares of Ducommun during the second quarter valued at about $175,000. Finally, American Financial Group Inc. acquired a new position in shares of Ducommun during the second quarter valued at about $219,000. Institutional investors and hedge funds own 80.60% of the company’s stock.

Ducommun Company Profile

Ducommun Incorporated is a global provider of engineering and manufacturing services for various products and applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. The Company is a solution-based provider, offering a range of value-added products and services in its primary businesses of electronics, structures and integrated solutions.

5 Day Chart for NYSE:DCO

Receive News & Stock Ratings for Ducommun Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun Inc. and related stocks with our FREE daily email newsletter.